Search Result "Spironolactone"


Research Article

The Impact of Spironolactone on Markers of Myocardial Oxidative Status, Inflammation and Remodeling in Hyperthyroid Rats

Journal: Current Molecular Pharmacology
Volume: 13 Issue: 3 Year: 2020 Page: 206-215
Author(s): Fadia A Mayyas,Ahmad I Aljohmani,Karem H Alzoubi

Research Article

Long-Lasting Effects of Spironolactone after its Withdrawal in Patientswith Hyperandrogenic Skin Disorders

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 2 Year: 2023 Page: 188-195
Author(s):

Research Article

Stability-Indicating HPLC Method for Determination of Spironolactone in Oral Liquids and Its Application to Stability Study

Journal: Current Pharmaceutical Analysis
Volume: 14 Issue: 3 Year: 2018 Page: 185-190
Author(s): Nattawadee Ruenwong,Pimwaree Lochirakanjanakul,Chanpa Tanthana,Jutima Boonleang

Research Article

Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Ratsby Targeting ABCA1 and microRNA-33

Journal: Current Pharmaceutical Design
Volume: 28 Issue: 16 Year: 2022 Page: 1367-1372
Author(s):

Research Article

Marinobufagenin in Urine: A Potential Marker of Predisposition to Ethanol and a Target for Spironolactone

Journal: Current Hypertension Reviews
Volume: 14 Issue: 1 Year: 2018 Page: 35-38
Author(s): Vladimir A. Kashkin,Elena V. Shekunova,Alexei Y. Egorov,Alexei Y. Bagrov

Research Article

The Impact of Spironolactone Co-administration on Cyclosporin Initial DosageOptimization for Pediatric Refractory Nephrotic Syndrome

Journal: Current Pharmaceutical Design
Volume: 30 Issue: 18 Year: 2024 Page: 1419-1432
Author(s):

Meta-Analysis

Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More thanan Anti-androgen? Evidence from a Systematic Review and Meta-analysis

Journal: Current Pharmaceutical Design
Volume: 29 Issue: 19 Year: 2023 Page: 1486-1496
Author(s): Mir Mahmood Asrar,Idrees Ayoub Shah,Imtiyaz Ahmad Wani,Mohd. Ashraf Ganie

Review Article

Advances in Heart Failure with Preserved Ejection Fraction Management -The Role of Sacubitril-Valsartan, Pirfenidone, Spironolactone and Empagliflozin:Is Success a Series of Small Victories?

Journal: Current Pharmaceutical Design
Volume: 29 Issue: 7 Year: 2023 Page: 502-508
Author(s): Vassilios P. Vassilikos

The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy

Journal: Current Drug Safety
Volume: 2 Issue: 1 Year: 2007 Page: 71-77
Author(s): Domenic A. Sica

Aldosterone Receptor Antagonists and Cardiovascular Disease: Do We Need a Change of the Guard?

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4 Issue: 2 Year: 2006 Page: 129-153
Author(s): Coty W. Jewell, Linley E. Watson, Jonathan Mock, David E. Dostal

Previous   Next

Go To   Results 1 - 1 of 515

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy